Total Net Assets: Helius Medical Technologies, Inc. (HSDT)

Helius Medical (HSDT) maintains pricing power due to its unique non-invasive brain stimulation method via the tongue, which is critical for motor recovery. The business relies on the production of portable neuroplasticity devices for US rehabilitation centers. The quotes provided below, valued at 0.16, complement the analysis. The company is currently scaling the PoNS system by expanding insurance coverage for individuals with multiple sclerosis.

Steady demand for Inertia neurostimulators creates a foundation for the growth of net assets, calculated as the difference between the total assets of Helius Medical (HSDT) and its total liabilities. By analyzing book value dynamics, an investor can promptly identify capital erosion prior to the publication of reports, assessing the company's ability to maintain financial stability amid the long-term integration of devices into clinical practice.